Sunday, January 17, 2021

Cannabis

Cannabis, Marijuana, Mary Jane, Growth, Cultivation Hydroponics

2020 Elections Create Unique Opportunity for Helix Technologies (HLIX)

2020 Elections Create Unique Opportunity for Helix Technologies (HLIX)

Can B Corp (CANB) Products, FDA Approved Medical Devices, Subsidiaries and Medical Team Among...

In this podcast, Mr. Stanley Teeple discusses the current state of Can B, FDA Products, Brands, and Subsidiaries including their own R&D and production facility.

Can B Corp (CANB) Expands Availability of Insurance Covered Duramed Ultrasound to the Entire...

Can B Corp (CANB) Expands Availability of Insurance Covered Duramed Ultrasound to the Entire State of Michigan

The Top Crypto Cannabis Coins Today: What You Need to Know

POT reached the $1 million cap in April 2014 but tanked immediately to $244,000 less than a month later. It looked as if it was staying on a downward trend until NBA legend Dennis Rodman wore a PotCoin.com shirt in a North Korean airport. As of January 2020 POT was priced at $0.0056 and is projected to be at $0.60 by the end of 2022.

Cannabics Pharmaceuticals (CNBX) receives “Intention to Grant a European Patent”

Cannabics Pharmaceuticals (CNBX) receives "Intention to Grant a European Patent"

Can B’s (CANB) Director and CFO, Stanley Teeple, to Update on Stock Market Podcast

In the podcast, Mr. Teeple will discuss the current state of Can B Corp, along with its subsidiaries, new product launches, its FDA approved medical device and its strong medical advisory team.

Can B Corp. (OTCQB: CANB) Partners with Dr. Karl Zarse to Launch ImmuneX2

Miami, FL –October 22, 2020, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for...

Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND Meeting Request for...

Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33

PAO Group, Inc. (PAOG) FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled...

PAO Group, Inc. (PAOG) FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday

Sugarmade (SGMD) Issues Letter to Shareholders on Coming Expansion Steps

Sugarmade (SGMD) Issues Letter to Shareholders on Coming Expansion Steps

Latest News

Stocks involved in Covid-19 Testing could be the all out Winners

Another solid player in the COVID-19 test kit market is Avalon GloboCare (NASDAQ: AVCO) who recently partnered with Adial Pharmaceuticals (NASDAQ: ADIL) announcing a Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices

Hydrogen Stocks, The New EV